Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer-Reference-Cited by-同舟云学术

Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer

Published:2010-05-22 Issue:1 Volume:125 Page:191-200
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Sedjo Rebecca L.,Devine Scott

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-010-0952-6.pdf

Reference36 articles.

1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics, 2009. CA Cancer J Clin 59:25–49

2. Chlebowski RT (2008) Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-positive early breast cancer. Breast Cancer Res Treat 112:25–34

3. Winer EP, Hudis C, Burstein HJ et al (2005) American Society of Clinical Oncology Clinical Technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol 23:1–11

4. Goldhirsch A, Ingle JN, Gelber RD et al (2009) Thresholds for therapies: highlights of the St. Gallen International Expert Consensus on the primary therapy for early breast cancer 2009. Ann Oncol 20(8):1319–1329

5. Charlson RW, Brown E, Burstein HJ et al (2006) NCCN Task Force Report: adjuvant therapy for breast cancer. J Natl Compr Cancer Netw 4(Suppl 1):S1–S26

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy;JNCI Cancer Spectrum;2024-08-12

2. Financial Toxicity Among Women with Breast Cancer Varies by Age and Race;Annals of Surgical Oncology;2024-07-29

3. Revisiting Combined Modality Therapy in Older Patients With Luminal Breast Cancer Through the Patient Lens;Journal of Clinical Oncology;2024-06-20

4. Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors;Acta Pharmaceutica;2023-12-01

5. Geographic Variations and the Associated Factors in Adherence to and Persistence with Adjuvant Hormonal Therapy for the Privately Insured women Aged 18–64 with Breast Cancer in Texas;Current Oncology;2023-03-29